Vitamin D and inflammatory bowel disease.

Area of Science:

• Immunology
• Gastroenterology
• Endocrinology

Background:

• Inflammatory bowel disease (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), are chronic inflammatory conditions of the gastrointestinal tract with uncertain origins.
• Recent research has focused on understanding IBD mechanisms and expanding treatment options, with significant progress in characterizing immune cells and inflammatory mediators.

Purpose of the Study:

• To explore the role of 1,25-Dihydroxyvitamin D(3) [1,25(OH)(2)D(3)], the active form of Vitamin D(3), in immune homeostasis.
• To investigate the potential of vitamin D and its derivatives as therapeutic adjuncts for IBD treatment.

Main Methods:

• Review of existing literature on vitamin D's immune-regulatory functions.
• Analysis of studies involving vitamin D administration in animal models of autoimmune diseases, including IBD.

Main Results:

• Vitamin D is essential for maintaining immune homeostasis, influencing both innate and adaptive immunity.
• Impaired vitamin D regulation is linked to autoimmune processes, including IBD development in animal models.
• Vitamin D administration improved immune-mediated symptoms in animal models of IBD.

Conclusions:

• Vitamin D possesses immune-regulatory properties beneficial for immune tolerance.
• Further research is warranted to evaluate vitamin D and its derivatives as potential therapeutic strategies for managing IBD.